19-35526682-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001166034.2(SBSN):c.1600G>T(p.Val534Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000132 in 1,511,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001166034.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SBSN | NM_001166034.2 | c.1600G>T | p.Val534Phe | missense_variant | 1/4 | ENST00000452271.7 | NP_001159506.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SBSN | ENST00000452271.7 | c.1600G>T | p.Val534Phe | missense_variant | 1/4 | 1 | NM_001166034.2 | ENSP00000430242.1 | ||
SBSN | ENST00000518157.1 | c.571G>T | p.Val191Phe | missense_variant | 2/5 | 1 | ENSP00000428771.1 | |||
SBSN | ENST00000588674.5 | c.315+1225G>T | intron_variant | 2 | ENSP00000468646.2 |
Frequencies
GnomAD3 genomes AF: 0.00000673 AC: 1AN: 148528Hom.: 0 Cov.: 30
GnomAD4 exome AF: 7.34e-7 AC: 1AN: 1362546Hom.: 0 Cov.: 40 AF XY: 0.00000148 AC XY: 1AN XY: 676922
GnomAD4 genome AF: 0.00000673 AC: 1AN: 148528Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 72272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2024 | The c.1600G>T (p.V534F) alteration is located in exon 1 (coding exon 1) of the SBSN gene. This alteration results from a G to T substitution at nucleotide position 1600, causing the valine (V) at amino acid position 534 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at